肺纤维化中的铁:一个新兴的治疗点
Chunyan Wang1, Shucheng Hua2, Lei Song2
1Department of General Practice, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Changchun, China.
Frontiers in physiology
|September 4, 2023
概括
作为细胞死亡的途径,铁亡因其在肺纤维化中的作用得到越来越多的认可. 向铁亡提供了一个有前途的新疗法策略,用于这种肺部疾病.
科学领域:
- 生物医学科学 生物医学科学
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
背景情况:
- 肺纤维化是一种进展性肺病,没有有效的治疗方法,其特点是细胞外基质沉积过多.
- 铁死是一种受调节的细胞死亡形式,与肺纤维化病原发生有关.
- 肺纤维化目前的治疗选择有限,需要新的治疗策略.
研究的目的:
- 审查铁死在肺纤维化中的新兴作用.
- 为了确定治疗肺纤维化的铁灭途径内的潜在的治疗点.
主要方法:
- 对研究铁亡和肺纤维化研究的文献综述.
- 对关键分子参与者和参与铁灭的信号通路的分析.
- 确定针对铁亡的潜在治疗干预措施.
主要成果:
- 铁亡的失调有助于肺纤维化的发展和进展.
- 治疗干预的关键目标包括谷氨过氧化酶4,核因子红色素2相关因子2和铁化.
- 向铁亡途径可能为治疗肺纤维化提供一种新的方法.
结论:
- 铁死是肺纤维化的一个重要的新兴治疗点.
- 进一步的研究对于开发针对肺纤维化的安全有效的铁化向疗法至关重要.
- 调节铁亡的干预措施可能可以预防或逆转纤维化肺病变.
相关概念视频
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
261
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
261
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
213
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
213
Pulmonary Hypertension: Classification and Pathogenesis
222
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
222
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
200
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
200


